AbbVie raised its full-year adjusted earnings guidance and reported higher first-quarter revenue, boosted by growth in its immunology and neuroscience portfolios.
Source link
AbbVie Raises FY Guidance on Immunology, Neuroscience Growth
Date:
More like thisRelated
Comcast Plans Company Split, Sending Shares Soaring 22%
The spinoff of NBCUniversal and Sky will separate the...
NBA free agency intel: What we’re hearing ahead of free agency
Jun 29, 2026, 07:00 AM ETWith the conclusion of...
U.S. and Iran set for new talks, Trump says, after Hormuz clashes threatened peace deal
JERUSALEM — The United States and Iran will hold...
BioPark Aquarium fully reopened following renovations
ALBUQUERQUE, N.M. (KRQE) – After about five months of renovations, the...